Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

897
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
897
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

822
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
822
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

699
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
699
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

47
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
47
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

81
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
81
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

58
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
58

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Flashbacks Through Time: Historical Development and Current Use of the Term "Flashback" in Psychedelic and Post-Traumatic Stress Disorder Research.

Psychiatric research and clinical practice·2026
Same author

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.

Psychotherapy and psychosomatics·2026
Same author

Support factors and barriers in the implementation of an app for refugees in an inpatient psychiatric setting: a qualitative interview study.

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2026
Same author

Barriers and Facilitators for the Implementation of an Online Portal in Hospital Mental Health Care: Implementation Study.

JMIR formative research·2026
Same author

Post-traumatic stress disorder symptoms following psychedelic use: a naturalistic survey study.

Psychological medicine·2026
Same author

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.

JAMA psychiatry·2026
Same journal

Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy.

Current topics in behavioral neurosciences·2026
Same journal

Managing Psychological Challenges in the Subacute ("Afterglow") Window of Psychedelic Drug Effects.

Current topics in behavioral neurosciences·2025
Same journal

Flashbacks, Hallucinogen Persisting Perception Disorder (HPPD), and Reactivations Following the Use of Classic Psychedelics: Classification and Therapeutic Management.

Current topics in behavioral neurosciences·2025
Same journal

Correction to: Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics.

Current topics in behavioral neurosciences·2025
Same journal

Ontologically Challenging Psychedelic Experiences: Considerations for Managing Associated Distress.

Current topics in behavioral neurosciences·2025
Same journal

The Role and Ethics of Touch and Non-touch in Psychedelic-Assisted Therapy.

Current topics in behavioral neurosciences·2025
查看所有相关文章

相关实验视频

Updated: Feb 28, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.9K

分类与迷幻相关的并发症

Tomislav Majić1,2, Euphrosyne Gouzoulis-Mayfrank3,4, Ricarda Evens5

  • 1Department of Psychiatry and Neurosciences, Campus Charité Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany. tomislav.majic@charite.de.

Current topics in behavioral neurosciences
|February 26, 2026
PubMed
概括
此摘要是机器生成的。

像psilocybin和LSD这样的经典迷幻药显示出治疗承诺,但也有风险. 了解迷幻药的并发症对于在治疗中安全使用至关重要.

关键词:
焦虑 焦虑是一种焦虑.分类 分类 分类 分类.脱人格化是一种脱人格化.没有实现,没有实现.在HPPD中,HPPD是最重要的.迷幻药物 迷幻药物精神错乱是一种精神病.

更多相关视频

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.4K
Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

12.2K

相关实验视频

Last Updated: Feb 28, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.9K
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.4K
Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
11:14

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

12.2K

科学领域:

  • 神经科学和精神病学 在
  • 药理学 药理学是指药理学的学科.
  • 临床心理学 临床心理学

背景情况:

  • 经典的迷幻药物 (psilocybin,LSD,5-MeO-DMT) 显示出对心理健康的治疗潜力.
  • 过于乐观的媒体描述导致非临床使用和并发症的增加.
  • 专业人士和研究人员往往低估了迷幻风险.

研究的目的:

  • 为提供与经典迷幻药物使用相关的并发症的概述.
  • 讨论将与迷幻相关的疾病归因于物质使用.
  • 考虑在诊断系统中对与迷幻相关的障碍进行分类.

主要方法:

  • 复习精神错乱并发症的历史和当前分类方法.
  • 心理效应 (急性,亚急性,长期) 的时间动态分析.
  • 讨论迷幻药的使用与精神障碍之间的因果关系.

主要成果:

  • 迷幻效应随着时间的推移而展开,具有明显的急性,亚急性和长期阶段.
  • 需要对与迷幻相关的风险和危害进行细致的分类.
  • 现有的分类可能会忽视与迷幻相关的特定并发症.

结论:

  • 一个全面的分类系统对于评估迷幻药物并发症至关重要.
  • 了解时间动态有助于管理风险并最大限度地提高治疗效益.
  • 这项工作为更安全的迷幻研究,治疗和非医疗用途提供了框架.